Ben Ponvilawan

14PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 06, 2026
Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung Cancer.

|Jun 16, 2025
Prevalence of genetic alterations in basal cell carcinoma patients resistant to Hedgehog pathway inhibitors: a systematic review.

Suvijak Untaaveesup, Pornteera Srichana, Gynna Techataweewan

|May 29, 2025
PD-L1 Expression in Biliary Tract Cancer: Comparison Across Antibody Clones and Role as a Predictor of Response to Chemoimmunotherapy: A Meta-Analysis.

Juan J Juarez-Vignon Whaley, Soravis Osataphan, Ben Ponvilawan

|Mar 28, 2024
Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors.

Ben Ponvilawan, Abdul Wali Khan, Janakiraman Subramanian

|Feb 28, 2024
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.

Yasuo Kubota, Xiaorong Gu, Laila Terkawi

|Aug 26, 2023
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets.

Minako Mori, Yasuo Kubota, Arda Durmaz

Pageof 3

Frequent Collaborators

4 joint publications

Patompong Ungprasert

3 joint publications

Nipith Charoenngam

3 joint publications

Yasuo Kubota

3 joint publications

Jaroslaw P Maciejewski